3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
174
Neoplasm Metastasis
139
Neoplasms
133
Leukemia, Myeloid, Acute
127
Colorectal Neoplasms
126
Breast Neoplasms
113
Melanoma
88
Ovarian Neoplasms
87
Prostatic Neoplasms
86
Recurrence
84
Multiple Myeloma
79
Pancreatic Neoplasms
74
Squamous Cell Carcinoma of Head and Neck
72
Glioblastoma
71
Lung Neoplasms
70
Lymphoma, Non-Hodgkin
62
Myelodysplastic Syndromes
60
Triple Negative Breast Neoplasms
56
Stomach Neoplasms
52
Glioma
52
Precursor Cell Lymphoblastic Leukemia-Lymphoma
49
Endometrial Neoplasms
47
Carcinoma, Renal Cell
47
Small Cell Lung Carcinoma
46
Lymphoma, Large B-Cell, Diffuse
44
Brain Neoplasms
43
Carcinoma, Hepatocellular
41
Sarcoma
39
Advanced Solid Tumors
39
Lymphoma, Follicular
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Blood Protein Disorders
×
90 days
×
Clear all
NCT07075185
2026-04-24
inMMyCAR
Kelonia Therapeutics, Inc.
Phase 1
Recruiting
70 enrolled